Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 077180
Company: PADAGIS ISRAEL
Company: PADAGIS ISRAEL
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
MOMETASONE FUROATE | MOMETASONE FUROATE | 0.1% | LOTION;TOPICAL | Prescription | AB | No | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/06/2005 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
10/08/2019 | SUPPL-9 | Labeling-Package Insert |
Label is not available on this site. |
||
07/27/2015 | SUPPL-4 | Labeling-Package Insert |
Label is not available on this site. |
MOMETASONE FUROATE
LOTION;TOPICAL; 0.1%
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
MOMETASONE FUROATE | MOMETASONE FUROATE | 0.1% | LOTION;TOPICAL | Prescription | No | AB | 077678 | COSETTE |
MOMETASONE FUROATE | MOMETASONE FUROATE | 0.1% | LOTION;TOPICAL | Prescription | No | AB | 075919 | FOUGERA PHARMS |
MOMETASONE FUROATE | MOMETASONE FUROATE | 0.1% | LOTION;TOPICAL | Prescription | No | AB | 090506 | GLENMARK PHARMS LTD |
MOMETASONE FUROATE | MOMETASONE FUROATE | 0.1% | LOTION;TOPICAL | Prescription | No | AB | 077180 | PADAGIS ISRAEL |
MOMETASONE FUROATE | MOMETASONE FUROATE | 0.1% | LOTION;TOPICAL | Prescription | No | AB | 076788 | TARO |